Plasma microRNAs as biomarkers of pancreatic cancer risk in a prospective cohort study

Metastatic Pancreatic Adenocarcinoma After Total Pancreatectomy Islet Autotransplantation for Chronic Pancreatitis

(2016) S. Muratore et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Plasma miRNAs Effectively Distinguish Patients With Pancreatic Cancer From Controls

(2016) Jianwei Xu et al.   ANNALS OF SURGERY

Cancer statistics, 2016

(2016) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Identification of a novel PPARβ/δ/miR‐21‐3p axis in UV‐induced skin inflammation

(2016) Gwendoline Degueurce et al.   EMBO Molecular Medicine

Digital next-generation sequencing identifies low-abundance mutations in pancreatic juice samples collected from the duodenum of patients with pancreatic cancer and intraductal papillary mucinous neoplasms

(2016) Jun Yu et al.   GUT

A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns

(2016) Faiyaz Notta et al.   NATURE

Genomic analyses identify molecular subtypes of pancreatic cancer

(2016) Peter Bailey et al.   NATURE

miRNA Deregulation in Cancer Cells and the Tumor Microenvironment

(2016) R. Rupaimoole et al.   Cancer Discovery

Detectable Symptomatology Preceding the Diagnosis of Pancreatic Cancer and Absolute Risk of Pancreatic Cancer Diagnosis

(2015) H. A. Risch et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Global Cancer Incidence and Mortality Rates and Trends--An Update

(2015) L. A. Torre et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells

(2015) Ryan Charles Pink et al.   GYNECOLOGIC ONCOLOGY

Contribution of microRNA analysis to characterisation of pancreatic lesions: a review

(2015) Michela Visani et al.   JOURNAL OF CLINICAL PATHOLOGY

MicroRNA in pancreatic adenocarcinoma: predictive/prognostic biomarkers or therapeutic targets?

(2015) Oronzo Brunetti et al.   Oncotarget

A Pilot Study to Develop a Diagnostic Test for Pancreatic Ductal Adenocarcinoma Based on Differential Expression of Select miRNA in Plasma and Bile

(2014) Gregory A Cote et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

MicroRNAs in pancreatic malignancy: Progress and promises

(2014) Sanjeev K. Srivastava et al.   CANCER LETTERS

Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

(2014) L. Rahib et al.   CANCER RESEARCH

Molecular Pathways: microRNAs, Cancer Cells, and Microenvironment

(2014) I. Berindan-Neagoe et al.   CLINICAL CANCER RESEARCH

MicroRNA Biomarkers in Whole Blood for Detection of Pancreatic Cancer

(2014) Nicolai A. Schultz et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Mir-155 promotes cervical cancer cell proliferation through suppression of its target gene LKB1

(2014) Guoying Lao et al.   TUMOR BIOLOGY

Estimating the Receiver Operating Characteristic Curve in Studies That Match Controls to Cases on Covariates

(2013) Margaret Sullivan Pepe et al.   ACADEMIC RADIOLOGY

Measures Taken to Restore the Danish Diet, Cancer and Health Biobank After Flooding: A Framework for Future Biobank Restorations

(2013) Nina Roswall et al.   BIOPRESERVATION AND BIOBANKING

MiR-106b expression determines the proliferation paradox of TGF-β in breast cancer cells

(2013) C Gong et al.   ONCOGENE

microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions

(2013) H Ouyang et al.   ONCOGENE

Upregulation of miRNA-155 promotes tumour angiogenesis by targeting VHL and is associated with poor prognosis and triple-negative breast cancer

(2013) W Kong et al.   ONCOGENE

From Differences in Means between Cases and Controls to Risk Stratification: A Business Plan for Biomarker Development

(2013) Nicolas Wentzensen et al.   Cancer Discovery

MicroRNA-10a is Overexpressed in Human Pancreatic Cancer and Involved in Its Invasiveness Partially via Suppression of the HOXA1 Gene

(2012) Kenoki Ohuchida et al.   ANNALS OF SURGICAL ONCOLOGY

miR-132 and miR-212 are increased in pancreatic cancer and target the retinoblastoma tumor suppressor

(2011) Jong-Kook Park et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MicroRNA-10b Expression Correlates with Response to Neoadjuvant Therapy and Survival in Pancreatic Ductal Adenocarcinoma

(2011) M. Preis et al.   CLINICAL CANCER RESEARCH

microRNA-10b: A New Marker or the Marker of Pancreatic Ductal Adenocarcinoma?

(2011) T. Setoyama et al.   CLINICAL CANCER RESEARCH

MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma

(2011) N. B. Jamieson et al.   CLINICAL CANCER RESEARCH

MicroRNA Alterations of Pancreatic Intraepithelial Neoplasias

(2011) J. Yu et al.   CLINICAL CANCER RESEARCH

MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis

(2011) Kohei Nakata et al.   SURGERY

MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity

(2010) Elisa Giovannetti et al.   CANCER RESEARCH

Fluorescence-Based Codetection with Protein Markers Reveals Distinct Cellular Compartments for Altered MicroRNA Expression in Solid Tumors

(2010) L. F. Sempere et al.   CLINICAL CANCER RESEARCH

MicroRNA-21 Is Induced Early in Pancreatic Ductal Adenocarcinoma Precursor Lesions

(2010) M. C. du Rieu et al.   CLINICAL CHEMISTRY

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

(2010) Shinichi Yachida et al.   NATURE

Aberrant MicroRNA-155 Expression Is an Early Event in the Multistep Progression of Pancreatic Adenocarcinoma

(2010) Ji Kon Ryu et al.   PANCREATOLOGY

MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood-Based Biomarkers of Disease

(2009) J. Wang et al.   Cancer Prevention Research

Retinoic Acid Receptor Antagonists Inhibit miR-10a Expression and Block Metastatic Behavior of Pancreatic Cancer

(2009) Frank Ulrich Weiss et al.   GASTROENTEROLOGY

Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival

(2009) Thomas Greither et al.   INTERNATIONAL JOURNAL OF CANCER

MicroRNAs in Cancer: Small Molecules With a Huge Impact

(2009) Marilena V. Iorio et al.   JOURNAL OF CLINICAL ONCOLOGY

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases

(2008) Xi Chen et al.   CELL RESEARCH

Analysis of MicroRNAs in Pancreatic Fine-Needle Aspirates Can Classify Benign and Malignant Tissues

(2008) A. E. Szafranska et al.   CLINICAL CHEMISTRY